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Abstract
Background: Altered blood glucose concentration is commonly observed in patients with sepsis, even among those 
without hypoglycemic treatments or history of diabetes mellitus. These alterations in blood glucose are potentially 
detrimental, although the precise relationship with outcome in patients with bacteremia has not been yet determined.
Methods: A retrospective cohort study design for analyzing patients with Gram negative rod bacteremia was 
employed, with the main outcome measure being in-hospital mortality. Patients were stratified in quintiles accordingly 
deviation of the blood glucose concentration from a central value with lowest mortality. Cox proportional-hazards 
regression model was used for determining the relationship of same day of bacteremia blood glucose and death.
Results: Of 869 patients identified 63 (7.4%) died. Same day of bacteremia blood glucose concentration had a U-
shaped relationship with in-hospital mortality. The lowest mortality (2%) was detected in the range of blood glucose 
concentration from 150 to 160 mg/dL. Greater deviation of blood glucose concentration from the central value of this 
range (155 mg/dL, reference value) was directly associated with higher risk of death (p = 0.002, chi for trend). The low-
risk group (quintile 1) had a mortality of 3.3%, intermediate-risk group (quintiles 2, 3 and 4) a mortality of 7.1%, and the 
high-risk group (quintile 5) a mortality of 12.05%. In a multivariable Cox regression model, the hazard ratio for death 
among patients in the intermediate-risk group as compared with that in the low risk group was 2.88 (95% confidence 
interval, 1.01 to 8.18; P = 0.048), and for the high risk group it was 4.26 (95% confidence interval, 1.41 to 12.94; P = 0.01).
Conclusions: Same day of bacteremia blood glucose concentration is related with outcome of patients with Gram-
negative rod bacteremia. Lowest mortality is detected in patients with blood glucose concentration in an interval of 
150-160 mg/dL. Deviations from these values are associated with an increased risk of death.
Background
Community acquired Gram-negative bacillus bacteremia
(GNB) is a leading cause of hospitalization, sepsis and
mortality [1]. Altered blood glucose concentration is fre-
quently detected in patients with sepsis and has been
associated with adverse outcome [2-9]. Variable cut-off
values of hospital admission blood glucose concentra-
tions with ranges from 100 to 200 mg/dL have been pre-
viously selected for defining outcome in observational
studies with different populations as patients with stroke
[10], head injuries [11], severe trauma [12], myocardial
infarction [13], community acquired pneumonia [14], or
patients admitted in a hospital through an emergency
department [15].
Based on the negative effects of hyperglycemia in criti-
cally ill patients, detected in observational studies, several
clinical trials that have tried to prove the benefits of its
prevention with intensive insulin therapy with disap-
pointing results. One of the reasons of these results is the
potential effect of tight control of glucose blood concen-
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trations causing hypoglycemia [16-18]. In fact hypoglyce-
mia is also associated with negative effect over prognosis.
In this situation there is a debate about the relevance of
control blood glucose range in critically ill patients in
general and specifically in patients with sepsis [19,20].
As there is limited information about outcome in rela-
tion with blood glucose concentrations in patients with
sepsis and/or bacteremia, we conducted a hospital-based
retrospective cohort study in order to investigate the
association between same day of bacteremia blood glu-
cose concentration (SDBGC) and mortality in patients
with GNB.
Methods
Hospital setting and patients
The Sierrallana Hospital is an adult acute-care center in
T orrelavega, a city in the North of Spain, which forms
part of a health district of 160000 inhabitants. It is a com-
munity teaching hospital with 250 beds that has approxi-
mately 8000 admissions and 65000 patient visits to the
emergency service annually. It includes most major
departments and specialties, except transplantation,
burns, thoracic surgery, cardiovascular surgery and neu-
rosurgery units. Blood cultures are performed at the hos-
pital in around 1800 patients per year.
A retrospective cohort study design was employed,
with the main outcome measure being in-hospital mor-
tality. Patients with Gram-negative rod bacteremia (GNB)
from January 1997 to December 2006 were identified by
using the microbiology laboratory database and their
charts were reviewed retrospectively with a standardized
data collection form. Only the community acquired epi-
sodes considered accordingly CDC criteria [21] were
included in this study cohort. Only the first episode of
bacteremia on each admission was included. One hun-
dred and twenty six nosocomial episodes and 23 episodes
with no blood glucose measurement recorded during the
same day of the bacteremia were excluded. The following
data were collected: age; sex; comorbid conditions; dates
of hospital admission and discharge; presence of septic
shock at the moment of blood culture extraction; specific
antimicrobials administered during hospitalization; dates
of start and end of antimicrobial administration; surgical
procedures and hospitalization in an intensive care unit.
The presence of each of the following comorbid condi-
tions was assessed at the time of bacteremia: hepatic dys-
function, malignancy, diabetes mellitus, renal
insufficiency, human immunodeficiency virus infection,
neutropenia, corticosteroid use, previous transplantation,
use of an immunosuppressive agent in the preceding 30
days. The study was approved by the Institutional Review
Board of the hospital (Comité Ético de Investigación
Clínica de Cantabria), which waived the need for
informed consent due to the retrospective nature of the
study.
Definitions
A localized focus infection was considered to be the
source or primary focus of bacteremia. Bacteremia was
c o n s i d e r e d  t o  h a v e  b e e n  n o s o c o m i a l l y  a c q u i r e d  i f  i t
appeared 48 h after admission and no evidence of infec-
tion was present on admission. The bacteremia was cate-
gorized as polymicrobial if additional microorganisms
were recovered from the blood cultures. The source of
the bacteraemia was determined on the basis of the isola-
tion of the same microorganism from the presumed por-
tal of entry and clinical evaluation. Renal insufficiency
was indicated by a creatinine value of 2.0 mg/dL. Neutro-
penia was defined as an absolute neutrophil count ≤500
cells/mm3 at the onset of the bacteraemia. Immunosup-
pression was defined as the presence of neutropenia or
HIV infection (with CD4 count ≤350 cells/mm3), or
receipt of immunosuppressive agents. Comorbidities
were assessed by using the Charlson comorbidity score
[22]. Septic shock was defined as proposed by Bone et al
[23]. Empirical antimicrobial therapy was judged to be
either adequate or inadequate on the basis of the in vitro
susceptibility of an isolated organism, and/or the initia-
tion of antibiotic treatment within 24 h of blood culture
extraction. Oxyimino-b-lactams (cefuroxime, cefotaxime,
ceftriaxone, ceftazidime and aztreonam) were considered
to be inappropriate regardless of the MIC for the treat-
ment of infections caused by ESBL-producing Gram-neg-
ative microorganisms. Therapy with urinary antiseptics
such as norfloxacin, fosfomycin, pipemidic acid or nali-
dixic acid was considered inadequate [24].
Blood cultures
The common practice for blood cultures at our hospital is
to obtain 20 mL of venous blood and to inoculate it in
equal parts into one aerobic (BacT/ALERT FA aerobic,
bioMérieux Corporation, Durham, North Carolina) and
one anaerobic blood culture bottle (BacT/ALERT FN,
bioMérieux). Blood drawn is performed by nurses from a
peripheral vein three times at intervals of 30 minutes. As
a routine practice at our hospital a positive finding of
microbial growth in the blood culture is reported to the
attending physicians before the results of antimicrobial
susceptibility test are known and organism identification
is established.
Same day of bacteremia blood glucose measurement
In patients with more than one blood glucose measure-
ment obtained on the same day of the bacteremia only the
first one was considered for the analysis. Blood glucose
tests were performed at the clinical chemistry laboratory
on venous samples by the glucose oxidase method.Peralta et al. BMC Infectious Diseases 2010, 10:181
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Statistical analysis
Bivariable analyses were conducted to determine the
association between potential risk factors and mortality.
Of primary interest was the association between blood
glucose concentration and in hospital mortality. Categor-
i c a l  d a t a  w e r e  c o m p a r e d  b y  t h e  c h i - s q u a r e  o r  F i s h e r ' s
exact tests. Quantitative data were compared by Student's
t test or the Mann-Whitney U test, as appropriate. To
evaluate the effect of different levels of blood glucose
concentration on mortality, relative risks and 95 percent
confidence intervals were calculated as hazard ratios
derived from the Cox proportional-hazards regression
model. Multivariable models were fitted with use vari-
ables with a P value < 0.1 in the univariate. The level of
significance was set at P < 0.05. The SPSS (version 14)
software package was used for all analyses.
Results
Patient population
During the study period, blood cultures were performed
in 18094 patients and were positive in 2678. Among
these, 1018 patients were identified as having GNB. After
considering inclusion/exclusion criteria, 869 cases were
analyzed. The demographic and clinical characteristics of
these patients are listed in Table 1. The median age of the
patients was 75 years (interquartile range, 64-82 years). In
721 (83%) blood cultures were obtained at the emergency
department, and in 821 (94.5%) blood glucose determina-
tion was performed in samples obtained in the emer-
gency department. Of the selected patients, 672 (77.3%)
were hospitalized and the remainder were diagnosed of
bacteremia after the patients had been discharged from
the emergency department and re-evaluated in an outpa-
tient clinic.
The main sites of infection were as follows: urinary in
484 patients (55.7%), biliary in 157 (18.1%); unknown in
116 (13.3%); abdominal in 37 (4.3%); enteric in 28 (3.2%);
pneumonia in 16 (1.8%), skin in 13 (1.5%) and spontane-
ous bacterial peritonitis in 8 (0.9%).
Blood glucose concentrations
The range of SDBGC was 52 to 582 mg/dL. The relation-
ship of mortality and blood glucose concentration
s h o w e d  a n  a s y m m e t r i c  U  s h a p e  d i s t r i b u t i o n  w i t h  t h e
lowest mortality among patients with glucose blood con-
centration of 151-160 mg/dL (Figure 1).
Patients were divided into subgroups according the dif-
ference of the blood glucose concentration with the cen-
tral value of the interval with lowest mortality (155 mg/
dL, reference value). Characteristics of these subgroups
(quintiles) are reflected in table 2. The proportion of
patients with diabetes mellitus or liver cirrhosis was
much higher among those classified in the 5th quintile. A
relationship between the absolute difference of blood glu-
Table 1: Demographic and clinical characteristics of 
patients with bloodstream infections due to Gram-
negative bacilli.
Characteristics Value
Demographics
Male sex 458 (52.7)
Age >65 y 635 (73.1)
Comorbidity
Diabetes mellitus 139 (16)
Neoplasm 81 (9.3)
COPD 81 (9.4)
Dementia 71 (8.2)
Liver cirrhosis 48 (5.5)
Stroke 51 (5.9)
Immunosuppression 37 (4.3)
Chronic renal failure 29 (3.4)
Charlson index ≥3 145 (16.7)
Microorganism
E. coli  710 (81.7)
Klebsiella spp. 53 (6.1)
Proteus spp. 44 (5.1)
Salmonella spp. 39 (4.5)
Enterobacter spp. 22 (2.5)
Polymicrobial bacteremia 67 (7.7)
Adequate empirical treatment 648 (74.6)
PresentationPeralta et al. BMC Infectious Diseases 2010, 10:181
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cose concentration respect the reference value and mor-
tality was detected (Figure 2).
On the basis of the findings presented in figure 2, we
combined subgroups into three categories designated as
low-risk (quintile 1, corresponding to blood glucose con-
centration from 140 to 170 mg/dL), intermediate-risk
(quintiles 2, 3 and 4, corresponding to blood glucose con-
centration from 93 mg/dL to 139 mg/dL and from 171
mg/dL to 217 mg/dL), and high-risk (quintile 5, corre-
sponding to blood glucose concentration <93 mg/dL or
greater than 217 mg/dL). Mortality in the intermediate-
risk category was 7.1% (95% Confidence interval: 5% to
9.3%), which was similar to the average mortality of 7.4%
for the entire cohort.
Predictors of mortality
Risk factors for death in a univariate analysis are reflected
in table 3. Kaplan-Meier estimates of survival for all sub-
jects according to blood glucose concentration risk cate-
g o r i e s  a r e  s h o w n  i n  f i g u r e  3 .  I n  a  m u l t i v a r i a b l e  C o x
regression model, the hazard ratio for death among
patients in the intermediate-risk group according to
blood glucose concentration as compared with that in the
low risk group was 2.88 (95 percent confidence interval,
1.01 to 8.18; P = 0.048), and for the high risk group it was
4.26 (95 percent confidence interval, 1.41 to 12.94; P =
0.01). Other factors associated with death are reflected in
table 4. When we selected non-diabetic patients for the
analysis the hazard ratio for death among patients in the
intermediate-risk group according to blood glucose con-
centration as compared with that in the low risk group
was 2.76 (95 percent confidence interval, 0.96 to 7.98; P =
0.06), and for the high risk group 5.11 (95 percent confi-
dence interval, 1.55 to 16.92; P = 0.008).
Discussion
In this cohort study of patients with GNB, SDBGC was
independently associated with prognosis. SDBGC had a
U-shaped relationship with in-hospital mortality with the
lowest mortality in patients with SDBGC of 150-160 mg/
dL. Based on the deviation of blood glucose concentra-
tion from the value with the lowest mortality, we classi-
fied patients in groups with low, intermediate, and high
risk categories of death. As compared with the low risk
blood glucose concentration category, intermediate risk
concentration category and high risk category were asso-
ciated with hazard ratios for death of 2.88 and 4.6, respec-
tively. The increased risk was similar for patients without
diabetes mellitus. Although several other studies have
made risk assessments for patients with GNB, this is, to
our knowledge, the first observational study to evaluate
the effect of the deviation from a reference level of blood
glucose concentration on outcome in this population.
Hyperglycemia associated with insulin resistance is
common in critically ill patients and, although it can be
considered an adaptive response, it has been associated
with outcome [2,7,16-18]. Several observational studies
have demonstrated that elevated initial blood glucose is
independently associated with prognostic of severe acute
illness [25]. However, the specific consequences of hyper-
glycemia in patients with sepsis have not quite been
addressed [7,8,19,26]. Hypoglycemia is also a manifesta-
tion of sepsis [2-5] and is associated with a worse out-
come in hospitalized patients with acute illnesses [4,6]
and specifically in patients with E. coli bacteremia [5].
As the initial altered blood glucose has been considered
detrimental in the last years several studies have evalu-
ated the effect of controlling blood glucose concentra-
tions in critically ill patients with insulin therapy over
mortality. A prospective randomized non-blind trial
showed that critical medical intensive care unit patients
had a slight and not significant reduction in ICU mortal-
ity of 2.8% when treated with intensive insulin therapy to
achieve target levels of blood glucose concentration from
80 to 100 mg/dL when compared with patients receiving
conventional glucose control (target blood glucose level
Septic shock 9 (1.0)
Outcome
Required ICU 29 (3.3)
In hospital mortality 63 (7.2)
Data are no. (%) of patients. ICU: Intensive care unit.
Table 1: Demographic and clinical characteristics of 
patients with bloodstream infections due to Gram-
negative bacilli. (Continued)
Figure 1 In hospital mortality according to blood glucose con-
centration. The numbers inside the bars reflect the number of pa-
tients in each group.
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Table 2: Baseline characteristics of patients with GNB according to quintiles of the absolute difference of the SDBGC 
respect the reference value of lowest mortality (155 mg/dL).
1st Quintile
n = 183
2nd Quintile
n = 190
3rd Quintile
n = 163
4th Quintile
n = 167
5th Quintile
n = 166
p
Range of difference in BGC with the reference value 
(mg/dL)
≤15 16-29 30-42 43-62 ≥63 -
Demographics
Male sex 59.0 53.7 54.0 54.5 41.6 0.02
Age >65 y 74.9 76.3 75.5 61.4 77.1 0.006
Comorbidity
Diabetes mellitus 10.4 11.1 6.8 4.2 49.1 <0.001
Neoplasm 10.4 10.5 9.3 10.2 6.1 0.59
COPD 9.3 13.2 9.9 7.8 6.1 0.2
Dementia 6.0 6.8 8.0 7.9 12.7 0.19
Liver cirrhosis 4.4 3.2 6.2 4.2 10.3 0.04
S t r o k e 5 . 56 . 3 3 . 16 . 67 . 90 . 4 4
I m m u n o s u p p r e s s i o n 4 . 42 . 1 3 . 76 . 05 . 50 . 3 9
Chronic renal failure 2.7 2.1 4.3 2.4 5.5 0.37
Charlson ≥3 11.5 16.1 13.8 18.5 14.8 0.57
Origin of infection
Urinary 49.5 55.0 55.3 63.0 59.1 0.12
Biliary 20.3 21.2 22.4 13.9 12.8 0.07
Unknown 17.6 12.2 12.4 9.1 15.9 0.16
Intra-abdominal 4.4 3.7 4.3 4.8 4.3 1
Pneumonia 1.1 1.6 1.2 2.4 3.0 0.64
Microorganism
E. coli  82.0 83.2 82.2 82.6 78.3 0.8Peralta et al. BMC Infectious Diseases 2010, 10:181
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Klebsiella spp. 6 . 03 . 7 6 . 76 . 67 . 80 . 5 6
Proteus spp. 4 . 45 . 8 6 . 14 . 84 . 20 . 9
Salmonella spp. 5 . 53 . 7 3 . 74 . 25 . 40 . 8 6
Enterobacter spp. 2 . 23 . 7 1 . 21 . 24 . 20 . 2 5
Adequate empirical treatment 82.6 80.3 85.8 81.8 83.7 0.7
P o l y m i c r o b i a l  b a c t e r e m i a 8 . 27 . 4 9 . 25 . 48 . 40 . 7 4
Presentation
Septic shock 0 0.5 1.8 1.2 1.8 0.35
Outcome
Required ICU 4.4 1.6 3.1 4.2 3.6 0.58
Death 3.3 6.3 7.4 7.8 12.0 0.03
Data are % of patients. ICU: Intensive care unit.
Table 2: Baseline characteristics of patients with GNB according to quintiles of the absolute difference of the SDBGC 
respect the reference value of lowest mortality (155 mg/dL). (Continued)
180-220 mg/dL) [17]. The study only demonstrated a
beneficial effect after the first three days of the intensive
insulin therapy [17]. Another multicenter randomized
prospective trial of intensive versus conventional glyce-
mic control in severe sepsis was closed prematurely
because of a nearly six fold increase in severe hypoglyce-
mia among the patients in the intensive glycemic control
treated group [26]. Moreover, the selection of a strict tar-
get blood glucose concentration is not supported by some
observational studies, which reveal that optimal blood
glucose concentration for these critically ill patients may
be higher [25]. On the other hand intensive insulin ther-
apy is potentially detrimental per se [16,17,27]. Although
hypoglycemia in hospitalized patients is harmful
[4,6,26,27], no information is reflected in the literature
about the optimal management of hypoglycemia in
patients with sepsis, except for causal treatment when
feasible.
Our results are consistent with some previous studies.
Finney et al [25] found in an observational study that a
target blood glucose level of around 145 mg/dL may be
associated with a better outcome in critically ill patients.
We have detected similar differences in mortality of 2.7%
than a previous randomized clinical trial, when we com-
pare patients with blood glucose concentration of 80-100
mg/dL and 180-200 mg/dL that were the end points
defined in that trial [17]. However, the optimal blood glu-
cose levels may be different after the first days of hospital
admission [17] and our data are referred to the day of the
bacteremia. One recent observational study from Austra-
lia in critically ill patients has detected also a U shape
relationship of blood glucose concentration with mortal-
Figure 2 Mortality according to deviation of blood glucose con-
centration with the reference blood glucose concentration of 155 
mg/dL which is the central value of the interval with the lowest 
mortality. Patients are distributed in quintiles of the difference in 
blood glucose concentration. The numbers inside the bars reflect the 
number of patients in each group (p = 0.002 chi square for linear 
trend).
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Table 3: Univariate analysis of factors associated with mortality in patients with GNB.
Surviving
N = 806
Death
N = 63
RR (95%CI) P
Demographics
Male 426 (52.9) 32 (50.8) 0.93 (0.58-1.49) 0.43
Age >65 y 581 (72.2) 54 (85.7) 2.20 (1.11-4.39) 0.01
Comorbidity
Diabetes mellitus 130 (16.2) 9 (14.3) 0.87 (0.56-2.41) 0.43
Neoplasm 74 (9.2) 7 (11.1) 1.2 (0.57-2.57) 0.38
Immunosuppression 31 (3.9) 6 (9.5) 2.36 (1.08-5.11) 0.046
Liver cirrhosis 41 (5.1) 7 (11.1) 2.13 (1.02-4.41) 0.052
Chronic renal failure 45 (5.6) 6 (9.5) 1.68 (0.76-3.71) 0.16
Charlson index ≥3 129 (16) 21 (33.3) 2.4 (1.46-3.92) 0.001
Microorganism
Escherichia coli  664 (82.4) 46 (73) 0.61 (0.36-1.03) 0.05
Klebsiella spp. 48 (6.0) 5 (7.9) 1.33(0.56-3.17) 0.34
Proteus spp. 40 (5.0) 4 (6.3) 1.27 (0.48-3.34) 0.4
Salmonella spp. 34 (4.2) 5 (7.9) 1.84 (0.78-4.32) 0.14
Enterobacter spp. 19 (2.4) 3 (4.8) 1.93 (0.65-5.67) 0.21
Polymicrobial bacteremia 56 (6.9) 11 (17.5) 2.56 (1.4-4.64) 0.006
Adequate empirical treatment 610 (83.7) 38 (70.4) 0.5 (0.28-0.86) 0.014
Origin of infection
Urinary 466 (58.3) 18 (29.0) 0.32 (0.19-0.54) <0.0001
Biliary 147 (18.4) 10 (16.1) 0.86 (0.45-1.66) 0.4
Unknown 101 (12.6) 15 (24.2) 2.05 (1.19-3.54) 0.013
Intra-abdominal 32 (4.09 5 (8.1) 1.95 (0.83-4.58) 0.12Peralta et al. BMC Infectious Diseases 2010, 10:181
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ity, with lowest levels of mortality in patients with blood
glucose concentrations among 100-150 mg/dL [28]. Simi-
larly with this study the U shape relationship of blood
glucose concentration with mortality that we have
detected is asymmetric and there was more increase in
mortality in patients with high than with low blood glu-
cose with respect the range with lowest mortality. If sep-
sis related mortality has a direct relationship with high or
low blood glucose concentration, it can be speculated
that increasing blood glucose concentration to achieve an
optimal target level could be of potential benefit. The
threshold to indicate correction of low blood glucose
concentration should first be determined [28].
Our study has several limitations. Data are retrospec-
tive and the results came from a population with specific
characteristics: patients with GNB, a low proportion of
immunosuppression, stay in ICU, septic shock or death,
so the extrapolation of these results must be made with
caution. As has been commented, the measurements of
blood glucose concentration were made at the beginning
of the illness, so it remains unknown whether the blood
glucose concentrations associated with the lowest mor-
tality would be the same after the initial phases of GNB.
However as we select initial blood glucose concentration
for the analysis, those are not influenced by therapies as
insulin, glucose-containing solutions or parenteral nutri-
tion used during hospitalizations.
In summary, our study indicates that low and high
blood glucose concentrations are associated with higher
mortality of patients with GNR bacteremia regardless of
the presence of diabetes mellitus. Studies to determine
the precise correlation between blood glucose concentra-
tion and mortality with suspected bacteremia are needed.
Conclusions
Same day of bacteremia blood glucose concentration is
related with outcome of patients with Gram-negative rod
bacteremia. Lowest mortality is detected in patients with
blood glucose concentration in an interval of 150-160
Pneumonia 10 (1.3) 6 (9.7) 5.66 (2.86-11.18) <0.001
Presentation
Septic Shock 4 (0.5) 5 (7.9) 8.24 (4.37-15.54) <0.0001
Data are no. (%) of patients. RR: Relative risk
Table 3: Univariate analysis of factors associated with mortality in patients with GNB. (Continued)
Table 4: Results of Cox analyses examining risk factors for 
mortality associated with bacteraemia due to Gram-
negative bacilli.
Mortality risk factor HR (95% CI) p value
Charlson index ≥3 2.04 (1.12-3.69) 0.02
Urinary origin 0.44 (0.23-0.82) 0.01
Lung origin 4.14 (1.54-11.08) 0.005
Polymicrobial bacteremia 2.6 (1.28-5.28) 0.008
Adequate empirical treatment 0.43 (0.23-0.79) 0.006
Shock 9.31 (3.42-25.38) <0.001
Blood glucose category (high vs 
low risk)
4.26 (1.4-12.9) 0.01
HR: hazard ratio
Figure 3 Adjusted estimates of overall survival in patients with 
GNB according to risk groups. The three risk groups are based in the 
quintiles of the absolute difference in glucose blood concentration 
with the central value of the interval with lowest mortality: low risk 
group (quintile 1), intermediate risk group (quintiles 2, 3 and 4), high 
risk group (quintile 5). Survival estimates have been adjusted for the 
presence of age >65 years, Charlson index ≥3, presence of immuno-
suppression, liver cirrhosis, urinary origin, lung origin, unknown origin, 
E. coli bacteremia, polymicrobial bacteremia, presence of shock and 
adequacy of empirical antibiotic treatment. P = 0.036 by the log-rank 
test for the overall comparison between groups.Peralta et al. BMC Infectious Diseases 2010, 10:181
http://www.biomedcentral.com/1471-2334/10/181
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mg/dL. Deviations from these values are associated with
an increased risk of death.
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